Reporter brief
RCT characterizing rapamycin pharmacokinetics and pharmacodynamics in older adults
What happened
This was a randomized controlled trial designed to characterize how rapamycin is processed and acts in the body in older adults. The study aimed to generate foundational pharmacokinetic and pharmacodynamic data needed to inform future clinical trials of mTOR inhibitors in aging-related conditions. No efficacy outcomes, sample sizes, or effect sizes were reported in the available material.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- University of Texas Southwestern Medical Center
- Published
- Jun 25, 2026
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.